671 related articles for article (PubMed ID: 27341533)
21. Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients.
Chmielewski M; Carrero JJ; Qureshi AR; Axelsson J; Heimbürger O; Berglund L; Bárány P; Rutkowski B; Lindholm B; Stenvinkel P
J Intern Med; 2009 Jun; 265(6):708-16. PubMed ID: 19298498
[TBL] [Abstract][Full Text] [Related]
22. Dyslipidemia is a strong predictor of myocardial infarction in subjects with chronic kidney disease.
Holzmann MJ; Jungner I; Walldius G; Ivert T; Nordqvist T; Ostergren J; Hammar N
Ann Med; 2012 May; 44(3):262-70. PubMed ID: 21114460
[TBL] [Abstract][Full Text] [Related]
23. Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes.
Taskinen MR; Barter PJ; Ehnholm C; Sullivan DR; Mann K; Simes J; Best JD; Hamwood S; Keech AC;
Diabetologia; 2010 Sep; 53(9):1846-55. PubMed ID: 20526762
[TBL] [Abstract][Full Text] [Related]
24. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
Yanni AE; Perrea DN; Yatzidis HA
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
[TBL] [Abstract][Full Text] [Related]
25. Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.
Erbel R; Lehmann N; Churzidse S; Möhlenkamp S; Moebus S; Mahabadi AA; Schmermund A; Stang A; Dragano N; Grönemeyer D; Seibel R; Kälsch H; Bauer M; Bröcker-Preuss M; Mann K; Jöckel KH;
Atherosclerosis; 2013 Aug; 229(2):531-40. PubMed ID: 23701995
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Lamprea-Montealegre JA; Staplin N; Herrington WG; Haynes R; Emberson J; Baigent C; de Boer IH;
Clin J Am Soc Nephrol; 2020 Jan; 15(1):47-60. PubMed ID: 31831577
[TBL] [Abstract][Full Text] [Related]
27. Reference intervals for six lipid analytes in 8-14 year-old school children from three different ethnical groups in the Hulun Buir area of China.
Du Y; Sun H; Li Y; Shi X; Pei D; Qi D; Wang B
Clin Lab; 2014; 60(8):1295-300. PubMed ID: 25185414
[TBL] [Abstract][Full Text] [Related]
28. Lipid levels, apolipoproteins, and risk of incident atrial fibrillation in men: A report from the Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD).
Tajik B; Tuomainen TP; Jarroch R; Kauhanen J; Lip GYH; Isanejad M
J Clin Lipidol; 2022; 16(4):447-454. PubMed ID: 35525793
[TBL] [Abstract][Full Text] [Related]
29. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
[TBL] [Abstract][Full Text] [Related]
30. Relationship of lipoproteins, apolipoproteins, triglycerides and lipid ratios to plasma total cholesterol in young adults: the CARDIA Study. Coronary Artery Risk Development in Young Adults.
Iribarren C; Belcher JD; Jacobs DR; Gross MD; Schreiner PJ; Sidney S
J Cardiovasc Risk; 1996 Aug; 3(4):391-6. PubMed ID: 8946271
[TBL] [Abstract][Full Text] [Related]
31. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
32. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
33. Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study.
Usui T; Nagata M; Hata J; Mukai N; Hirakawa Y; Yoshida D; Kishimoto H; Kitazono T; Kiyohara Y; Ninomiya T
J Atheroscler Thromb; 2017 Jul; 24(7):706-715. PubMed ID: 27840387
[TBL] [Abstract][Full Text] [Related]
34. ApoB/ApoA-I ratio is independently associated with carotid atherosclerosis in type 2 diabetes mellitus with well-controlled LDL cholesterol levels.
Jun JE; Choi YJ; Lee YH; Kim DJ; Park SW; Huh BW; Lee EJ; Jee SH; Hur KY; Choi SH; Huh KB
Korean J Intern Med; 2018 Jan; 33(1):138-147. PubMed ID: 29334727
[TBL] [Abstract][Full Text] [Related]
35. The effects on lipid and apolipoprotein serum levels of long-term carbamazepine, valproic acid and phenobarbital therapy in children with epilepsy.
Eirís J; Novo-Rodríguez MI; Del Río M; Meseguer P; Del Río MC; Castro-Gago M
Epilepsy Res; 2000 Aug; 41(1):1-7. PubMed ID: 10924863
[TBL] [Abstract][Full Text] [Related]
36. Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease.
van den Berg MJ; van der Graaf Y; de Borst GJ; Kappelle LJ; Nathoe HM; Visseren FLJ;
Am J Cardiol; 2016 Sep; 118(6):804-810. PubMed ID: 27471056
[TBL] [Abstract][Full Text] [Related]
37. Association of the ApoB/ApoA-I ratio with stroke risk: Findings from the China Health and Nutrition Survey (CHNS).
Liu D; Zhang Y; Wang C; Zuo H
Nutr Metab Cardiovasc Dis; 2022 Jan; 32(1):203-209. PubMed ID: 34916118
[TBL] [Abstract][Full Text] [Related]
38. Effect of age on the association of non-high-density-lipoprotein cholesterol and apolipoprotein B with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the Casale Monferrato study.
Bruno G; Merletti F; Biggeri A; Bargero G; Prina-Cerai S; Pagano G; Cavallo-Perin P
Diabetologia; 2006 May; 49(5):937-44. PubMed ID: 16525840
[TBL] [Abstract][Full Text] [Related]
39. Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).
Albers JJ; Slee A; O'Brien KD; Robinson JG; Kashyap ML; Kwiterovich PO; Xu P; Marcovina SM
J Am Coll Cardiol; 2013 Oct; 62(17):1575-9. PubMed ID: 23973688
[TBL] [Abstract][Full Text] [Related]
40. apoB/apoA-I Ratio and Lp(a) Associations With Aortic Valve Stenosis Incidence: Insights From the EPIC-Norfolk Prospective Population Study.
Zheng KH; Arsenault BJ; Kaiser Y; Khaw KT; Wareham NJ; Stroes ESG; Boekholdt SM
J Am Heart Assoc; 2019 Aug; 8(16):e013020. PubMed ID: 31407609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
